# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA677210 | B | In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay | 28 | cell-based format | Scientific Literature | |||
2. | ALA680029 | B | Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells | 16 | cell-based format | Scientific Literature | |||
3. | ALA678320 | B | FGFR-1 (FTK) inhibitory activity at 2 uM of ATP in vitro. | 33 | single protein format | Scientific Literature | |||
4. | ALA694959 | B | Concentration required to inhibit the human liver recombinant fructose-1,6-bisphosphatase. | 37 | assay format | Scientific Literature | |||
5. | ALA704660 | F | In vitro inhibitory activity against EGF-stimulated proliferation of KB2 cells in culture | Homo sapiens | 29 | cell-based format | Scientific Literature | ||
6. | ALA705978 | F | Inhibition of EGF-stimulated proliferation of KB cells in culture | Homo sapiens | 16 | cell-based format | Scientific Literature | ||
7. | ALA734902 | F | In vivo concentration in blood levels in mice assay at a dose of 200 mg/kg by oral administration after 2 hours | Mus musculus | 1 | organism-based format | Scientific Literature | ||
8. | ALA734903 | F | In vivo concentration in blood levels in mice assay at a dose of 200 mg/kg by oral administration after 24 hours | Mus musculus | 21 | organism-based format | Scientific Literature | ||
9. | ALA734905 | A | Blood levels in mice 6 hour post oral dose (200 mg/kg) | Mus musculus | 27 | organism-based format | Scientific Literature | ||
10. | ALA765908 | B | Compound was evaluated for its concentration required to inhibit the porcine kidney F16BPase | 8 | single protein format | Scientific Literature | |||
11. | ALA765114 | F | Compound was evaluated for its concentration required to inhibit the rabbit liver F16BPase | Oryctolagus cuniculus | 8 | organism-based format | Scientific Literature | ||
12. | ALA797742 | B | Compound was evaluated for its concentration required to inhibit the rat liver F16BPase | 8 | assay format | Scientific Literature | |||
13. | ALA811931 | B | In vitro vascular endothelial growth factor receptor 1 inhibitory activity at 2 uM of ATP. | 35 | single protein format | Scientific Literature | |||
14. | ALA812620 | B | Vascular endothelial growth factor receptor 2 inhibitory activity at 2 uM of ATP in vitro. | 33 | single protein format | Scientific Literature | |||
15. | ALA852073 | B | Ratio of IC50 of FGFR-1 (FTK) to VEGFR-2 (KDR). | 29 | protein format | Scientific Literature | |||
16. | ALA2020642 | B | Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting | Homo sapiens | 65 | cell-based format | Scientific Literature | ||
17. | ALA2020643 | B | Inhibition of recombinant human VEGFR-2 using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting | Homo sapiens | 65 | single protein format | Scientific Literature | ||
18. | ALA2020644 | F | Antiproliferative activity against human PC3 cells after 72 hrs by MTS assay | Homo sapiens | 4 | cell-based format | Scientific Literature | ||
19. | ALA2020645 | F | Antiproliferative activity against human HT-29 cells after 72 hrs by MTS assay | Homo sapiens | 14 | cell-based format | Scientific Literature | ||
20. | ALA2020646 | F | Antiproliferative activity against human MCF7 cells after 72 hrs by MTS assay | Homo sapiens | 11 | cell-based format | Scientific Literature |